When most of us think of coronavirus stocks, we think of vaccine makers or companies developing therapeutics. We probably don’t think of medical device players specializing in heart pumps.
Since June, hospitals have been using Abiomed‘s (NASDAQ: ABMD) heart pumps to help COVID-19 patients through serious heart and lung events. The most severe coronavirus complications affect these organs — so it’s clear Abiomed may be an important player in this field, right alongside vaccine-makers and drug developers. But does that mean you should buy the stock? Let’s take a closer look at Abiomed’s products and overall business.